Triple Moving Average Crossover
|Bid||45.36 x 800|
|Ask||45.38 x 1400|
|Day's Range||45.15 - 46.09|
|52 Week Range||19.50 - 58.93|
|Beta (5Y Monthly)||1.12|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 23, 2020 - Jul 27, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||47.38|
Kaskela Law LLC announces that it is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (Nasdaq: MMSI) on behalf of the Company's stockholders.
Starboard will take three seats on the board of Merit Medical, a maker of disposable medical devices. Also, Ascendis Pharma and Spectrum Brands see big investors lower stakes.
Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors Announces Formation of Operating.
The WRAPSODY system is a flexible self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within central veins as well as the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft. Merit has worked for almost eight years to design, develop and establish the appropriate technology and manufacturing capabilities for this product. Merit recently completed enrollment and primary follow-up of its WRAPSODY FIRST study which included 46 patients in Europe.
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SAN DIEGO, CA / ACCESSWIRE / May 19, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in (NYSE:MMSI) shares. Investors, who purchased shares of Merit Medical ...
Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics.
PHILADELPHIA, PA / ACCESSWIRE / April 25, 2020 / Kaskela Law LLC is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ:MMSI) on behalf of the Company's ...
Pomerantz LLP is investigating claims on behalf of investors of Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation concerns whether Merit Medical and certain of its officers and/or directors have breached fiduciary duties owed to the company and its investors. If you are a shareholder of Merit Medical and are interested in obtaining additional information regarding this investigation, you are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext.
Q1 2020 worldwide revenue of $243.5 million, up 2.2% as reported over Q1 2019Q1 2020 core revenue on a constant currency basis* up 3.0% over Q1 2019Q1 2020 GAAP loss per share.
NEW YORK, NY / ACCESSWIRE / April 23, 2020 / Merit Medical Systems, Inc. (NASDAQ:MMSI) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on April 23, 2020 at ...
A Relative Strength Rating upgrade for Merit Medical Systems shows improving technical performance. Will it continue?
The kit will be produced at Merit’s facility in South Jordan, Utah, with other Utah companies providing various services. For the last several weeks, officials from Merit and the State of Utah have been working together in anticipation of an impending swab shortage. “We have directed resources to the development of this kit, and our engineers, technicians, marketers and production staff have responded by working tirelessly to bring this important product to market in 30 days,” said Fred P. Lampropoulos, Merit’s Chairman and CEO.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
PHILADELPHIA, PA / ACCESSWIRE / April 18, 2020 / Kaskela Law LLC is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ:MMSI) on behalf of the Company's ...
Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Merit Medical Systems, Inc. (NASDAQ: MMSI) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between February 26, 2019 and October 30, 2019. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics.
SOUTH JORDAN, Utah, April 14, 2020 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in.
The WRAPSODY system is a flexible, self-expanding endoprosthesis. If the system is approved by the FDA for these indications, Merit believes the expanded indications will increase patient access to this life-saving technology.
*Core revenue is a non-GAAP financial measure. A reconciliation of core revenue to GAAP revenue is included under the heading “Non-GAAP Financial Measures” below. SOUTH.
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of federal and state laws by certain officers of the companies listed below.
SOUTH JORDAN, Utah, March 18, 2020 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,.
San Diego, California--(Newsfile Corp. - March 17, 2020) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Merit Medical Systems, Inc. (NYSE: MMSI).Investors, who purchased shares of Merit Medical Systems, Inc. (NYSE: MMSI), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.On December 3, 2019, a lawsuit was filed against Merit Medical Systems, Inc over alleged Securities ...
Merit Medical Systems Inc. is eliminating 134 jobs at its Malvern manufacturing plant, which it is closing this year as part of a previously announced consolidation plan. The layoffs, disclosed in a Worker Adjustment and Retaining Notification (WARN) filed with the state Department of Labor and Industry, will occur between May 1 and Dec. 30. The company, in its filing, said a "few select employees" may remain in Malvern following the closing of the plant for research and development and/or quality operations.